Reported a revenue of approximately USD 390 million, a 42.9% YoY increase, and a gross profit of USD 260 million, achieving YoY growth of 41.9%.
Tag: Financial
Jennifer Environmentally friendly Joins Knutson Development as Chief Financial Officer
TipRanks 3 Major Dividend Stocks Yielding at Minimum 8% Analysts Say ‘Buy’ We’ll chat about dividend shares, but we’ll get there via tax policy. The
Z Cash Team Appoints Annie Shick Running Director and Chief Financial Officer
TipRanks Goldman Sachs Bets on These 3 Shares Sees More than 50% Upside Prospective What goes up need to come down, as we all know.
Jeff Bezos’ financial commitment fund is backing a startup hoping to be the AWS for SMB accounting
Benzinga Penny Stocks Are Now The Key Target For Reddit Investors Why Are Reddit Penny Shares These kinds of A Large Concentrate? A short while
Suez Canal website traffic halt could elevate charges of items, jolt US financial system
The grounding of a significant container ship in the Suez Canal has clogged one of the world’s most vital trade routes and risks sending a
Navis to Be Acquired by Primary Technological know-how Financial investment Organization Accel-KKR
OAKLAND, Calif.–(Business WIRE)–Navis, a provider of operational systems and products and services that unlock greater efficiency and performance for the world’s leading organizations across the
Unity Financial institution Names Sector Veteran George Boyan Chief Economical Officer
CLINTON, N.J., March 26, 2021 (Globe NEWSWIRE) — Banking field veteran George Boyan has joined Unity Lender as Main Financial Officer (CFO) bringing additional than
OSE Immunotherapeutics Reports 2020 Financial Results and Provides Business Update
Major expansion of clinical portfolio including initiation of clinical trials with Tedopi® in ovarian cancer, OSE-127/S95011 in ulcerative colitis, FR104 in renal transplant and an
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
MINNEAPOLIS, March 25, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients
Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update
MARLBOROUGH, Mass., March 25, 2021 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its